PTK2 and ovarian carcinoma: Functional assays confirmed that stable PTK2 knockdown inhibited proliferation, colony formation, and migration while promoting apoptosis in ovarian cancer cells.<h4>Conclusion</h4>Our findings suggest that PTK2 may act as a putative oncogenic mediator and potential pharmacological link between lorazepam signaling and ovarian cancer progression.